Vaginal microbicides: A novel approach to preventing sexual transmission of HIV

被引：17

作者：

Doncel G. ^{[1
]}

Mauck C. ^{[1
]}

机构：

[1] CONRAD, Eastern Virginia Medical School, 601 Colley Avenue, Norfolk, 23507, VA

来源：

Current HIV/AIDS Reports | 2004年 / 1卷 / 1期

关键词：

Bacterial Vaginosis; Human Immunodeficiency Virus; Human Immunodeficiency Virus Infection; Human Immunodeficiency Virus Transmission; Human Immunodeficiency Virus Type;

D O I：

10.1007/s11904-004-0004-0

中图分类号：

学科分类号：

摘要：

The AIDS epidemic continues its unrelentless expansion. According to the Joint United Nations Programme on HIV/AIDS, there are more than 40 million people living with HIV, and more than 15,000 new infections occur every day. One approach to curbing HIV is the development of topical microbicidal agents or microbicides. These are compounds designed to protect the body’s mucosal surfaces from infection by sexually transmitted diseasecausing pathogens, including HIV. Several candidates are in preclinical stages; however, only a handful have been tested in humans for safety, and even fewer are ready for clinical efficacy trials. In this update, we describe microbicide research and development, including preclinical screening algorithms, ideal properties, compounds in the pipeline, and future prospects. This review is based on a previous work, which has been updated to contain new information, especially regarding microbicide candidates in preclinical and clinical stages of development. © 2004, Current Science Inc.

引用

页码：25 / 32

页数：7

共 61 条

[31]

Herold B.C., Bourne N.G., Marcellino D., Et al., Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases, J Infect Dis, 181, pp. 770-773, (2000)

[32]

Witvrouw M., Fikkert V., Pluymers W., Et al., Polyanionic (ie, polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/ integrase) in the virus replicative cycle, Mol Pharmacol, 58, pp. 1100-1108, (2000)

[33]

Bourne N., Stanberry L.R., Kern E.R., Et al., Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection, Antimicrob Agents Chemother, 44, pp. 2471-2474, (2000)

[34]

Zaneveld L.J., Anderson R.A., Diao X.H., Et al., Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis, Fertil Steril, 78, pp. 1107-1115, (2002)

[35]

Herold B.C., Scordi-Bello I., Cheshenko N., Et al., Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry, J Virol, 76, pp. 11236-11244, (2002)

[36]

Neurath A.R., Microbicide for prevention of sexually transmitted diseases using a pharmaceutical excipient, AIDS Patient Care STDS, 14, pp. 215-219, (2000)

[37]

Neurath A.R., Strick N., Li Y.Y., Anti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides, BMC Infect Dis, 2, (2002)

[38]

Shenoy S.R., O'Keefe B.R., Bolmstedt A.J., Et al., Selective interactions of human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins, J Pharmacol Exp Ther, 2, (2001)

[39]

Chiba H., Inokoshi J., Okamoto M., Et al., Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities, Biochem Biophys Res Commun, 282, pp. 595-601, (2001)

[40]

Irvin J.D., Uckun F.M., Pokeweed antiviral protein: ribosome inactivation and therapeutic applications, Pharmacol Ther, 55, pp. 279-302, (1992)

← 1 2 3 4 5 6 7 →